Respiratory Syncytial Virus—A Comprehensive Review
Top Cited Papers
- 12 April 2013
- journal article
- review article
- Published by Springer Science and Business Media LLC in Clinical Reviews in Allergy & Immunology
- Vol. 45 (3), 331-379
- https://doi.org/10.1007/s12016-013-8368-9
Abstract
Respiratory syncytial virus (RSV) is amongst the most important pathogenic infections of childhood and is associated with significant morbidity and mortality. Although there have been extensive studies of epidemiology, clinical manifestations, diagnostic techniques, animal models and the immunobiology of infection, there is not yet a convincing and safe vaccine available. The major histopathologic characteristics of RSV infection are acute bronchiolitis, mucosal and submucosal edema, and luminal occlusion by cellular debris of sloughed epithelial cells mixed with macrophages, strands of fibrin, and some mucin. There is a single RSV serotype with two major antigenic subgroups, A and B. Strains of both subtypes often co-circulate, but usually one subtype predominates. In temperate climates, RSV infections reflect a distinct seasonality with onset in late fall or early winter. It is believed that most children will experience at least one RSV infection by the age of 2 years. There are several key animal models of RSV. These include a model in mice and, more importantly, a bovine model; the latter reflects distinct similarity to the human disease. Importantly, the prevalence of asthma is significantly higher amongst children who are hospitalized with RSV in infancy or early childhood. However, there have been only limited investigations of candidate genes that have the potential to explain this increase in susceptibility. An atopic predisposition appears to predispose to subsequent development of asthma and it is likely that subsequent development of asthma is secondary to the pathogenic inflammatory response involving cytokines, chemokines and their cognate receptors. Numerous approaches to the development of RSV vaccines are being evaluated, as are the use of newer antiviral agents to mitigate disease. There is also significant attention being placed on the potential impact of co-infection and defining the natural history of RSV. Clearly, more research is required to define the relationships between RSV bronchiolitis, other viral induced inflammatory responses, and asthma.Keywords
This publication has 508 references indexed in Scilit:
- Influence of maternal asthma on the cause and severity of infant acute respiratory tract infectionsJournal of Allergy and Clinical Immunology, 2012
- Induction of mucosal and systemic immunity against respiratory syncytial virus by inactivated virus supplemented with TLR9 and NOD2 ligandsVaccine, 2012
- Decreased lung function after preschool wheezing rhinovirus illnesses in children at risk to develop asthmaJournal of Allergy and Clinical Immunology, 2011
- IL-17–Induced Pulmonary Pathogenesis during Respiratory Viral Infection and Exacerbation of Allergic DiseaseThe American Journal of Pathology, 2011
- The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic childrenJournal of Allergy and Clinical Immunology, 2010
- The human neonatal B cell response to respiratory syncytial virus uses a biased antibody variable gene repertoire that lacks somatic mutationsMolecular Immunology, 2009
- Respiratory Syncytial Virus Vaccine DevelopmentClinics in Laboratory Medicine, 2009
- The severity-dependent relationship of infant bronchiolitis on the risk and morbidity of early childhood asthmaJournal of Allergy and Clinical Immunology, 2009
- Predictive value of respiratory syncytial virus-specific IgE responses for recurrent wheezing following bronchiolitisThe Journal of Pediatrics, 1986
- Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody levelThe Journal of Pediatrics, 1981